載入...
Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis
Targeted therapies within the RAS/RAF/MEK/ERK signalling axis become increasingly popular, yet cross-talk and feedbacks in the signalling network lead to unexpected effects. Here we look systematically into how inhibiting RAF and MEK with clinically relevant inhibitors result in changes in PI3K/AKT...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4884967/ https://ncbi.nlm.nih.gov/pubmed/26799289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6959 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|